We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Reliance Gen. | LSE:GMX | London | Ordinary Share | GB00B1MM9925 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.55 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMGMX RNS Number : 3053T Reliance GeneMedix PLC 27 September 2010 FOR IMMEDIATE RELEASE 27th September 2010 Reliance GeneMedix plc (AIM: GMX) Reliance GeneMedix plc, the AIM listed biopharmaceutical company, announces that at the Annual General Meeting held on 24th September 2010 all resolutions were duly passed. The Company also announces that the General Meeting pursuant to provisions of section 656 of the Companies Act 2006 was held on 24th September 2010 and shareholders were informed that the Company remains fully funded by its parent, Reliance Life Sciences Private Limited. ENQUIRIES: Reliance GeneMedix plc Tel: +353 57 932 3572 Vinay Ranade, Chief Executive Officer Deloitte Corporate Finance Tel: +44 (0)20 7936 3000 Jonathan Hinton, John Ball Lothbury Financial Services Limited Tel: +44 (0)20 7868 2010 Michael Padley This information is provided by RNS The company news service from the London Stock Exchange END RAGUSOVRRVAKUAR
1 Year Reliance Genemedix Chart |
1 Month Reliance Genemedix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions